Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supernatant: What's in a name?

Cancer cytopathology·2026
Same author

Next-generation sequencing using a targeted gene panel in advanced solid tumors: five years of experience from an Italian referral institution.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study.

Pathologica·2026
Same author

Exploring genomic analysis and methylome profiling in longitudinal series of p.G12C KRAS mutated NSCLC patients treated with sotorasib.

The journal of liquid biopsy·2026
Same author

Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma.

Journal of the American Society of Cytopathology·2026
Same author

FKBP5 isoforms shape immune pathways related to tumor tolerance.

Cell death discovery·2026
Same journal

Pleural Fluid Cytology Detects Small Cell Carcinoma Transformation in EGFR-Mutant Lung Adenocarcinoma: A Case Report.

Diagnostic cytopathology·2026
Same journal

Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder.

Diagnostic cytopathology·2026
Same journal

Pleural Effusion Cytology of Metastatic Sclerosing Epithelioid Fibrosarcoma.

Diagnostic cytopathology·2026
Same journal

Turnaround Time Trends in Cervical Cytology Screening in South Africa, 2005-2023.

Diagnostic cytopathology·2026
Same journal

Spontaneous Infarction of Benign Salivary Gland Tumors: A Series of 5 Cases.

Diagnostic cytopathology·2026
Same journal

Atypical Carcinoid Tumor Metastatic to the Parotid Gland: A Case Report and Review of the Literature.

Diagnostic cytopathology·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.7K

EGFR analysis: current evidence and future directions.

Claudio Bellevicine1, Umberto Malapelle, Caterina de Luca

  • 1Department of Public Health, Anatomic Pathology Section, University of Naples Federico II, Naples, Italy.

Diagnostic Cytopathology
|March 13, 2014
PubMed
Summary
This summary is machine-generated.

Cytological samples are now suitable for epidermal growth factor receptor (EGFR) mutation testing in lung cancer, expanding options beyond traditional histology. This shift supports targeted cancer therapy and refines diagnostic guidelines for cytopathologists.

Keywords:
EGFRaspirationcytologylung cancernext generation sequencing

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Experiment Videos

Last Updated: May 2, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.7K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Area of Science:

  • Oncology
  • Molecular Pathology
  • Cytopathology

Background:

  • Historically, only lung cancer histological specimens were used for epidermal growth factor receptor (EGFR) mutation testing.
  • Recent studies have validated the use of parallel cytological and histological samples.
  • Prospective clinical experiences now support routine testing on cytological specimens.

Purpose of the Study:

  • To review the suitability of cytological samples for EGFR mutation testing.
  • To inform cytopathologists about advancements in targeted cancer therapy.
  • To help refine current guidelines for EGFR mutation testing.

Main Methods:

  • Review of retrospective and prospective studies on cytological samples.
  • Analysis of techniques including direct cytologic smears, cell blocks, and liquid-based cytology.
  • Examination of current European practice of external centralized testing on limited cell samples.

Main Results:

  • Cytological samples are now considered suitable for EGFR testing by major pathology organizations.
  • Various techniques demonstrate efficacy for EGFR mutation detection in cytology.
  • Challenges exist with current centralized testing models using paucicellular samples.

Conclusions:

  • Cytological samples are a viable alternative to histological specimens for EGFR mutation testing.
  • Cytopathologists play a crucial role in multidisciplinary cancer care.
  • Future directions include implementing next-generation sequencing in lung cytology.